Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
A minority of patients with Alport syndrome develop anti-GBM disease in their allografts after renal transplantation. Clinically, the renal disease appears indistinguishable from Goodpasture's disease of native kidneys, in which the target of autoantibodies had been identified as the NC1 domain of the alpha 3 chain of type IV collagen, alpha 3(IV)NC1. However, in the majority of cases, Alport syndrome is due to mutations in the gene encoding the alpha 5 chain of type IV collagen, located on the X chromosome. Neither chain is detectable in the glomerular basement membrane (GBM) of most patients with Alport syndrome. We investigated the targets of the alloantibodies of 12 Alport patients who developed post-transplant anti-GBM disease by Western blotting onto recombinant NC1 domains made in insect cells. Binding to these antigens, for both typical Goodpasture and Alport anti-GBM antibodies, was strong and conformation-sensitive. Nine antibodies showed selective binding to alpha 5(IV)NC1. This specificity was confirmed by the demonstration of binding to a 26 kDa band of collagenase-solubilized human GBM, and/or binding to normal epidermal as well as renal basement membranes by indirect immunofluorescence. One antibody showed binding to alpha 5 and alpha 3(IV)NC1, while two showed predominant binding to alpha 3(IV)NC1. All seven patients whose pedigree or mutation analysis showed X-linked inheritance had predominant anti-alpha 5 reactivity. One with predominant anti-alpha 3 reactivity had a COL4A3 mutation. These findings show that human anti-GBM disease can be associated with antibodies directed towards different molecular targets. Alpha 5(IV)NC1 is the primary target in most patients with X-linked Alport syndrome who develop post-transplant anti-GBM disease.
Brainwood
D
D
Department of Medicine, University of Aberdeen, Scotland, United Kingdom.
Kashtan
C
C
Gubler
M C
MC
Turner
A N
AN
D000595:Amino Acid Sequence; D019867:Anti-Glomerular Basement Membrane Disease / Q000209:etiology* / Q000235:genetics / Q000276:immunology*; D001483:Base Sequence; D001485:Basement Membrane / Q000276:immunology; D003094:Collagen / Q000235:genetics / Q000276:immunology; D017931:DNA Primers / Q000235:genetics; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D007519:Isoantigens / Q000235:genetics; D007678:Kidney Glomerulus / Q000276:immunology*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology*; D009394:Nephritis, Hereditary / Q000276:immunology* / Q000601:surgery*
D017931:DNA Primers; D007518:Isoantibodies; D007519:Isoantigens; D003094:Collagen